A Randomized Clinical Trial of Shenbai Granules in Reducing Recurrence of Colorectal Adenoma

NCT03616444 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2023-11-13

No results posted yet for this study

Summary

This study evaluates Shenbai Granules in Prevention of Colorectal Adenomatous Polyp Recurrence After Colonoscopy.Half of participants will receive Shenbai Granules,while the other half will receive a placebo.

Conditions

  • Gastroenterology

Interventions

DRUG

Shenbai Granules

In the first year, the trial granules will be started after enrollment for 3 months; In the second year, the trial granules will be started in the first 3 months; Each participant should have completed 6 months of trial granules.

Sponsors & Collaborators

  • Affiliated Hospital of Nanjing University of Chinese Medicine

    collaborator OTHER
  • Guangdong Provincial Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • Shanghai University of Traditional Chinese Medicine

    collaborator OTHER
  • ShuGuang Hospital

    collaborator OTHER
  • The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine

    collaborator OTHER
  • Changhai Hospital

    collaborator OTHER
  • Beijing Friendship Hospital

    collaborator OTHER
  • The First Affiliated Hospital with Nanjing Medical University

    collaborator OTHER
  • West China Hospital

    collaborator OTHER
  • Jiangsu Famous Medical Technology Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Chen Yugen, PhD · Key members of the study

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-03
Primary Completion
2023-06-28
Completion
2023-06-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03616444 on ClinicalTrials.gov